Sales decline 6.20% to Rs 754.91 crore
Net profit of Alembic Pharmaceuticals declined 23.79% to Rs 105.04 crore in the quarter ended December 2017 as against Rs 137.83 crore during the previous quarter ended December 2016. Sales declined 6.20% to Rs 754.91 crore in the quarter ended December 2017 as against Rs 804.79 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales754.91804.79 -6 OPM %21.2624.34 -PBDT160.15195.80 -18 PBT133.77174.05 -23 NP105.04137.83 -24Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
